about
Rethinking headache chronificationObesity and pre-hypertension in family medicine: implications for quality improvement.Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study.Depressive symptoms and migraine comorbidity among pregnant Peruvian women.Habituation to pain in "medication overuse headache": a CO2 laser-evoked potential study.Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis.Shared genetic factors in migraine and depression: evidence from a genetic isolate.Sleep disturbances and quality of life in Sub-Saharan African migraineurs.Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache.Defining the differences between episodic migraine and chronic migraine.One-day behavioral treatment for patients with comorbid depression and migraine: a pilot study.Altered effective connectivity of posterior thalamus in migraine with cutaneous allodynia: a resting-state fMRI study with Granger causality analysis.Phenotypic features of chronic migraineStress and sleep duration predict headache severity in chronic headache sufferers.Diagnosis and treatment for chronic migrainePrevalence and characteristics of allodynia in headache sufferers: a population study.Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines.Evidence of increased restless legs syndrome occurrence in chronic and highly disabling migraineComplementary and conventional medicine use among youth with recurrent headachesCutaneous allodynia in the migraine population.How clinicians can detect, prevent and treat medication overuse headache.Chronic migraine and medication overuse headache: clarifying the current International Headache Society classification criteria.Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications.Non-pharmacological approaches to treating chronic migraine with medication overuse.Overuse of acute migraine medications and migraine chronification.Migraine in the triptan era: progresses achieved, lessons learned and future developments.One-day behavioral intervention in depressed migraine patients: effects on headache.Is chronic migraine a primary or a secondary condition?Stress and tension-type headache mechanisms.Chronic migraine: epidemiology and disease burden.Uncommon headache syndromes in the pediatric population.Comorbidity between migraine and depression: update on traditional and alternative treatments.What future for treatment of chronic migraine with medication overuse?Migraine and depression: common pathogenetic and therapeutic ground?Cortical excitability in chronic migraine.Pediatric migraine teaching for families.Beyond neurovascular: migraine as a dysfunctional neurolimbic pain network.Panic disorder and migraine: comorbidity, mechanisms, and clinical implications.Refractory migraine - a review.
P2860
Q27007657-BFCEA7A1-D667-49D0-98FE-0F0DD513022DQ33312104-B3E0A3FC-07D6-4378-8309-7A08FE1A172AQ33515892-87CD6149-8F02-4B1B-8CB2-0BB17ED5DD8CQ33716687-CE2F519D-9110-4201-8CDE-DAE768CD65D0Q34237210-E5252492-1801-4838-8DAE-EEBE0054B5FEQ34300935-792AE9C6-0D9F-4A79-94E4-036C7C79A18CQ35065444-7B98F5F5-8139-48BE-87A3-E9E1DE89ACD0Q35266693-39F55B1C-E26D-4075-B7AD-3FED300C3C38Q35539662-703C05A6-AC05-499B-B11E-BE015D68B0DFQ35672977-44D87032-419C-4720-B025-C0DBAEF9B418Q36129264-4A7D3B88-50DE-43F0-8EF1-029FDBF18B88Q36626138-C6FCBE02-0D9C-4E1B-8BBC-72E957CA7B12Q36685887-91E4D17C-FBB9-42CA-B5D1-2C22E05AEEACQ36765681-9503E06A-741A-4FA3-9FC5-C50D68D35DB9Q36925875-C23FDA1C-797A-4655-8719-27A19C03D9D9Q37148294-75E62B53-8E9B-4F4D-91B1-C93F06A492B7Q37176670-AC41B16B-1260-4420-AFC0-904D8A87B8D0Q37189727-FAB61321-0DB4-4A9E-A360-19C8EF64B210Q37267254-8E6EA047-6648-483F-8281-B1B0E94DE351Q37268861-A139CD53-E644-4A16-AA16-3572E036831DQ37312063-6E2AA9E5-B78D-444A-BE7B-2E8F1379B100Q37317164-A760C69C-FE4F-43D2-BBCA-993DF85A9953Q37416364-8135A733-3FA3-4617-B1A5-161DAACEDFCFQ37470296-22683A78-5043-4880-A7FD-F0B97D98F20DQ37470302-483D6FFF-8D06-4B30-8B04-E436C4E193E2Q37544942-F6C02E89-C4F0-4D3F-9574-B36329E154BEQ37558323-B1272F28-8462-47AB-9676-3498A3D42936Q37709238-3765E190-02AD-456F-8FB5-41E4727F723CQ37750558-B670C242-D49B-44B6-AE2D-1DAD478757B1Q37793010-CE024463-5E9E-4E37-9C3D-951344C03CF0Q37808388-4FF17AFB-76A5-4DD9-BE49-BA1AF54E6C5AQ37853047-81B3D6A3-0CEF-4F53-AAE1-CEAFD0119928Q37870779-005D1B86-1B93-41B6-890B-3D4AF1C2A049Q37870782-F80AC421-5FDB-4169-9F24-70F86BEA22A9Q37870787-08344BC2-8ECE-48ED-83F2-F31A8F1F2795Q37955113-F34B0684-760D-42E5-94CC-96FB793A07D0Q37998551-BD5DE8E3-4FD2-4A96-A6BC-52CA516B7462Q38023501-49D18B0C-EA1F-4FC9-AD32-A01B6CFD684CQ38070731-3D9B9B58-91F9-462E-966B-DB03AFD229F1Q38081178-B60C9674-42F9-474C-A53D-CE8C7565136D
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Modifiable risk factors for migraine progression.
@ast
Modifiable risk factors for migraine progression.
@en
type
label
Modifiable risk factors for migraine progression.
@ast
Modifiable risk factors for migraine progression.
@en
prefLabel
Modifiable risk factors for migraine progression.
@ast
Modifiable risk factors for migraine progression.
@en
P2860
P1433
P1476
Modifiable risk factors for migraine progression.
@en
P2860
P304
P356
10.1111/J.1526-4610.2006.00577.X
P577
2006-10-01T00:00:00Z